RECTAL CANCER RECURRENT
Clinical trials for RECTAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for RECTAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for rectal cancer never got off the ground
Disease control TerminatedThis study planned to test two drugs—regorafenib (a pill) and lorigerlimab (given by IV)—in people whose rectal cancer had come back or grown after standard treatment. The goal was to see if the combination was safe and effective. However, the trial was withdrawn before enrolling…
Matched conditions: RECTAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study aims to make complex pelvic cancer surgery safer
Disease control ENROLLING_BY_INVITATIONThis study looks at standardizing the surgical process for patients with advanced or recurrent rectal cancer that has spread to nearby organs. The procedure, called pelvic exenteration, removes the tumor along with affected structures. The goal is to improve teamwork among surgeo…
Matched conditions: RECTAL CANCER RECURRENT
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC